Search alternatives:
na decrease » nn decrease (Expand Search), pa decreased (Expand Search), la decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
na decrease » nn decrease (Expand Search), pa decreased (Expand Search), la decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
241
-
242
-
243
-
244
-
245
-
246
-
247
-
248
Decrease in comet tail moment (TM) with increasing concentration of () melphalan and () SJG-136 in AA8 cells
Published 2011“…For each drug concentration, the TM of 50 cells was measured and the mean values calculated. …”
-
249
-
250
-
251
-
252
-
253
A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels.
Published 2014“…<sup>#</sup>P<0.05; <sup>##</sup> P<0.01; <sup>###</sup> P<0.001 between bars, two-way ANOVA followed by Bonferroni test. Scale bars: 50 µm. fPSA: functional PSA mimetic peptide; MAP-2: microtubule-associated protein 2; NCAM: neural cell adhesion molecule; SYN: synaptophysin.…”
-
254
20E repressed ILP-mediated cell membrane translocation of HaP60 and HaP110, dephosphorylated HaP60 and HaP110, and decreased their interaction.
Published 2021“…Green, HaP60 or HaP110; red, cell membrane stained with WGA; blue, nuclei stained with DAPI; merge, overlapped green, blue, and red fluorescence. Bar, 50 μm. <b>C.</b> Co-IP assay showed that 20E decreased the HaP60–HaP110 interaction and induced dephosphorylation in cells. …”
-
255
-
256
-
257
-
258
-
259
The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years.
Published 2017“…Metabolic syndrome: presence of at least three of the following criteria: a waist circumference ≥90 cm for men or ≥80 cm for women, triglycerides ≥150 mg/dL, an HDL cholesterol ≤40 mg/dL for males or ≤50 mg/dL for females, a systolic blood pressure ≥130 mm Hg or a diastolic blood pressure ≥85 mmHg and a fasting plasma glucose ≥100 mg/dL. …”
-
260